Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03666897 · ClinicalTrials.gov registry record · NA
Markers of Recovery in StrokE Study (MORSE)
A NA study, sponsored by Corewell Health West.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03666897 is a NA study that has completed, run by Corewell Health West. The registered enrollment target is 21 participants.
The verdict
NCT03666897, a NA study, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Our current biological understanding of stroke recovery in humans is extremely limited and this lack of knowledge is a major challenge in reducing stroke disabilities and deficits. Evidence of neural repair in humans can be gleaned indirectly through functional outcome measures, but we propose that metabolomics may also provide a minimally invasive window into human brain repair. This study will integrate clinical imaging and molecular biomarkers as a diagnostic tool in further understanding stroke recovery mechanisms.
Interventions
- OTHER DTI Images and Plasma Biomarkers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03666897
The ClinicalTrials.gov registry entry for NCT03666897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DTI Images and Plasma Biomarkers is the first listed.
NCT03666897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03666897 about?
NCT03666897 is a clinical study titled "Markers of Recovery in StrokE Study (MORSE)". Our current biological understanding of stroke recovery in humans is extremely limited and this lack of knowledge is a major challenge in reducing stroke disabilities and deficits. Evidence of neural repair in humans can be gleaned indirectly through functional outcome measures, but we propose that ...
What is the current status of trial NCT03666897?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-10-01. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT03666897?
The interventions under investigation include: DTI Images and Plasma Biomarkers (OTHER).
Who is sponsoring clinical trial NCT03666897?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.